Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pathogens & immunity

Showing results (11-20 of 210) with videos related to

Pageof 21
Sort By:
Pathogens & Immunity|November 28, 2019
Urinary Metabolites of Green Tea as Potential Markers of Colonization Resistance to Pathogenic Gut Bacteria in MiceMark E Obrenovich, George E Jaskiw, Thriveen Sankar Chittoor Mana, et al.
Pathogens & Immunity|December 5, 2017
Ten Years HIV Free: An Interview with "The Berlin Patient," Timothy Ray BrownMichael M Lederman, Earl Pike
Pathogens & Immunity|July 18, 2017
Association of Anisocytosis with Markers of Immune Activation and Exhaustion in Treated HIVSadeer G Al-Kindi, David A Zidar, Grace A McComsey, et al.
Pathogens & Immunity|August 19, 2017
Never Let a Crisis Go to Waste: Recruiting the Next Generation of Infectious Diseases PhysiciansCurtis J Donskey
Pathogens & Immunity|December 23, 2016
Increasing Rates of Fluoroquinolone Resistance in <i>Escherichia coli</i> Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant RecipientsChristopher G Hauck, Pearlie P Chong, Melissa B Miller, et al.
Pathogens & Immunity|August 9, 2016
Interferons and HIV Infection: The Good, the Bad, and the UglyNetanya S Utay, Daniel C Douek
Pathogens & Immunity|April 8, 2020
Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective StudyAntonio Muscatello, Silvia Nozza, Massimiliano Fabbiani, et al.
Pathogens & Immunity|April 8, 2020
Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic TreatmentKonstantinos Thomas, Emilia Hadziyannis, Chrisoula Hatzara, et al.
Pathogens & Immunity|April 22, 2017
A Comparison of Molecular Typing Methods Applied to <i>Enterobacter cloacae</i> complex: <i>hsp60</i> Sequencing, Rep-PCR, and MLSTRoberto A Viau, Lee M Kiedrowski, Barry N Kreiswirth, et al.
Pathogens & Immunity|May 18, 2018
Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD<sub>4</sub> CellsFred R Sattler, Daniel Chelliah, Xingye Wu, et al.
Pageof 21

Showing results (11-20 of 210) with videos related to

Sort By:
Pageof 21
Pathogens & Immunity|November 28, 2019
Urinary Metabolites of Green Tea as Potential Markers of Colonization Resistance to Pathogenic Gut Bacteria in MiceMark E Obrenovich, George E Jaskiw, Thriveen Sankar Chittoor Mana, et al.
Pathogens & Immunity|December 5, 2017
Ten Years HIV Free: An Interview with "The Berlin Patient," Timothy Ray BrownMichael M Lederman, Earl Pike
Pathogens & Immunity|July 18, 2017
Association of Anisocytosis with Markers of Immune Activation and Exhaustion in Treated HIVSadeer G Al-Kindi, David A Zidar, Grace A McComsey, et al.
Pathogens & Immunity|August 19, 2017
Never Let a Crisis Go to Waste: Recruiting the Next Generation of Infectious Diseases PhysiciansCurtis J Donskey
Pathogens & Immunity|December 23, 2016
Increasing Rates of Fluoroquinolone Resistance in <i>Escherichia coli</i> Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant RecipientsChristopher G Hauck, Pearlie P Chong, Melissa B Miller, et al.
Pathogens & Immunity|August 9, 2016
Interferons and HIV Infection: The Good, the Bad, and the UglyNetanya S Utay, Daniel C Douek
Pathogens & Immunity|April 8, 2020
Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective StudyAntonio Muscatello, Silvia Nozza, Massimiliano Fabbiani, et al.
Pathogens & Immunity|April 8, 2020
Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic TreatmentKonstantinos Thomas, Emilia Hadziyannis, Chrisoula Hatzara, et al.
Pathogens & Immunity|April 22, 2017
A Comparison of Molecular Typing Methods Applied to <i>Enterobacter cloacae</i> complex: <i>hsp60</i> Sequencing, Rep-PCR, and MLSTRoberto A Viau, Lee M Kiedrowski, Barry N Kreiswirth, et al.
Pathogens & Immunity|May 18, 2018
Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD<sub>4</sub> CellsFred R Sattler, Daniel Chelliah, Xingye Wu, et al.
Pageof 21